Fabrizio, Vanessa |
NCT05579639: Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant |
|
|
| Recruiting | 2 | 419 | US | Xylitol, Spiffies Xylitol Wipes, Placebo, Grape-Flavored Wipes | Children's Hospital Medical Center, Cincinnati, National Institute of Dental and Craniofacial Research (NIDCR) | Allogeneic Stem Cell Transplantation | 03/26 | 06/27 | | |
REFUEL, NCT05460533: A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL) |
|
|
| Recruiting | 2 | 33 | US | Tisagenlecleucel | Memorial Sloan Kettering Cancer Center, Novartis Pharmaceuticals | B-cell Acute Lymphoblastic Leukemia | 07/26 | 07/26 | | |
NCT04544592: UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL |
|
|
| Recruiting | 1/2 | 50 | US | CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells | University of Colorado, Denver, National Cancer Institute (NCI) | B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma | 06/26 | 07/26 | | |
| Recruiting | 1/2 | 20 | US | Afamitresgene autoleucel | Adaptimmune | Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neuroblastoma, Osteosarcoma | 10/26 | 07/38 | | |
NCT06559189: CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL |
|
|
| Recruiting | 1 | 26 | US | CD19x22 CAR T | University of Colorado, Denver | B-cell Acute Lymphoblastic Leukemia | 12/28 | 12/29 | | |